학술논문
Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with Imatinib
Document Type
Correspondence
Author
Source
In Cancer Genetics and Cytogenetics 2009 189(1):63-67
Subject
Language
ISSN
0165-4608